REGN7041

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN7041, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants [Phase 1, Phase 2]